Clinical trials
Phase 1/2 Hodgkin Disease trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
8 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2014 | 2 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 1 |
| 2023 | 1 |
| 2024 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 4 |
| Recruiting | 2 |
| Completed | 1 |
| Not yet recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Chinese PLA General Hospital | 2 |
| Akeso | 1 |
| AstraZeneca | 1 |
| Han weidong | 1 |
| Peking University | 1 |
| Shanghai Jiao Tong University School of Medicine | 1 |
| Yang Yang | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hodgkin Disease | 8 |
| Lymphoma | 2 |
| Lymphoma, Non-Hodgkin | 2 |
| Recurrence | 2 |
| Lymphoma, Large B-Cell, Diffuse | 1 |
| Lymphoma, Large-Cell, Anaplastic | 1 |
| Lymphoma, T-Cell | 1 |
| Lymphoma, T-Cell, Peripheral | 1 |
| Nasopharyngeal Carcinoma | 1 |
| Stomach Neoplasms | 1 |
Trials
Showing 1 to 8 of 8. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.